Notice for elexacaftor, tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
elexacaftor, tezacaftor, ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet and granules
Indication
Treatment of cystic fibrosis (CF)
Therapeutic area
Respiratory